| Published Application/Species/Sample/Dilution | Reference |
|---|
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Shin H, Lee W, Ku K, Yoon G, Moon H, Kim C, et al. SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation. Signal Transduct Target Ther. 2024;9:125 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Warner B, Chan M, Tailor N, Vendramelli R, Audet J, Meilleur C, et al. Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques. Vaccines (Basel). 2024;12: pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Albert M, Uranga Murillo I, Arias M, De Miguel D, Pe xf1 a N, Montinaro A, et al. Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality. Cell Death Differ. 2024;31:544-557 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| xc1 vila Nieto C, Vergara Alert J, Amengual Rigo P, Ainsua Enrich E, Brustolin M, Rodr xed guez de la Concepci xf3 n M, et al. Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection. Nat Commun. 2024;15:2349 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Yang Z, Johnson B, Meliopoulos V, Ju X, Zhang P, Hughes M, et al. Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity. Cell Rep. 2024;43:113965 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Fumagalli V, Rav xe0 M, Marotta D, Di Lucia P, Bono E, Giustini L, et al. Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination. Nat Immunol. 2024;25:633-643 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Losada A, Izquierdo Useros N, Aviles P, Vergara Alert J, Latino I, Segal xe9 s J, et al. Plitidepsin as an Immunomodulator against Respiratory Viral Infections. J Immunol. 2024;212:1307-1318 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Usai C, Ainsua Enrich E, Gales V, Pradenas E, Lorca Or xf3 C, Tarr xe9 s Freixas F, et al. Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models. NPJ Vaccines. 2024;9:48 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| de Campos Mata L, Trinit xe9 B, Modrego A, Tejedor Vaquero S, Pradenas E, Pons Gr xed fols A, et al. A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity. Nat Commun. 2024;15:1051 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Funk L, Poschmann G, Rabe von Pappenheim F, Chari A, Stegmann K, Dickmanns A, et al. Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design. Nat Commun. 2024;15:411 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Li K, Verma A, Li P, Ortiz M, Hawkins G, Schnicker N, et al. Adaptation of SARS-CoV-2 to ACE2H353K mice reveals new spike residues that drive mouse infection. J Virol. 2024;98:e0151023 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Liu J, Jaijyan D, Chen Y, Feng C, Yang S, Xu Z, et al. Cytomegalovirus-vectored COVID-19 vaccines elicit neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.2) in mice. Microbiol Spectr. 2023;11:e0246323 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Ng A, Hu H, Wang K, Scherler K, Warren S, Zollinger D, et al. Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2. Cell Rep. 2023;42:113212 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Narayan R, Sharma M, Yadav R, Biji A, Khatun O, Kaur S, et al. Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo. Cell Rep Med. 2023;:101127 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Xu D, Jiang W, Wu L, Gaudet R, Park E, Su M, et al. PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection. Nature. 2023;619:819-827 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Yang Z, Johnson B, Meliopoulos V, Ju X, Zhang P, Hughes M, et al. Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication. bioRxiv. 2023;: pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Ra xef ch Regu xe9 D, Tenorio R, Fern xe1 ndez de Castro I, Tarr xe9 s Freixas F, Sachse M, Perez Zsolt D, et al. β-Cyclodextrins as affordable antivirals to treat coronavirus infection. Biomed Pharmacother. 2023;164:114997 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Min Y, Huang M, Feng K, Jia Y, Sun X, Ning Y. A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications. Mol Cell Proteomics. 2023;22:100579 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Bojkova D, Bechtel M, Rothenburger T, Kandler J, Hayes L, Olmer R, et al. Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection. J Med Virol. 2023;95:e28686 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Ball E, Weiss C, Liu H, Jackson K, Keel M, Miller C, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Vasculopathy in a Syrian Golden Hamster Model. Am J Pathol. 2023;193:690-701 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Carius P, Jungmann A, Bechtel M, Gri xdf mer A, Boese A, Gasparoni G, et al. A Monoclonal Human Alveolar Epithelial Cell Line ("Arlo") with Pronounced Barrier Function for Studying Drug Permeability and Viral Infections. Adv Sci (Weinh). 2023;10:e2207301 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Pastor Fern xe1 ndez A, Bertos A, Sierra Ram xed rez A, Del Moral Salmoral J, Merino J, de xc1 vila A, et al. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice. Aging Cell. 2023;22:e13771 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Faist A, Schloer S, Mecate Zambrano A, Janowski J, Schreiber A, Boergeling Y, et al. Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. Antiviral Res. 2023;209:105475 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Xu F, Wang G, Zhao F, Huang Y, Fan Z, Mei S, et al. IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 Susceptibility. Viruses. 2022;14: pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Mesci P, de Souza J, Martin Sancho L, Macia A, Saleh A, Yin X, et al. SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir. PLoS Biol. 2022;20:e3001845 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Zacharias M, Kashofer K, Wurm P, Regitnig P, Sch xfc tte M, Neger M, et al. Host and microbiome features of secondary infections in lethal covid-19. iScience. 2022;25:104926 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Frische A, Brooks P, Gybel Brask M, S xe6 kmose S, Jensen B, Mikkelsen S, et al. Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay. PLoS ONE. 2022;17:e0272298 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Cui Z, Zeng C, Huang F, Yuan F, Yan J, Zhao Y, et al. Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection. Nat Chem Biol. 2022;18:1056-1064 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Tarr xe9 s Freixas F, Trinit xe9 B, Pons Gr xed fols A, Romero Durana M, Riveira Mu xf1 oz E, xc1 vila Nieto C, et al. Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice. Front Microbiol. 2022;13:840757 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Stegmann K, Dickmanns A, Heinen N, Blaurock C, Karrasch T, Breithaupt A, et al. Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication. iScience. 2022;25:104293 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Pipolo C, Bottai D, Fuccillo E, Aronica E, Bruschi F, Bulfamante A, et al. Evidence of SARS-CoV-2 in nasal brushings and olfactory mucosa biopsies of COVID-19 patients. PLoS ONE. 2022;17:e0266740 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Yeo G, Xiang J, Mueller J, Luo E, Yee B, Schafer D, et al. Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions. Res Sq. 2022;: pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Liang Q, Wang Y, Zhang S, Sun J, Sun W, Li J, et al. RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants. iScience. 2022;25:104043 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Zhou J, Peacock T, Brown J, Goldhill D, Elrefaey A, Penrice Randal R, et al. Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway. Cell Rep. 2022;38:110344 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Vidal E, L xf3 pez Figueroa C, Rodon J, P xe9 rez M, Brustolin M, Cantero G, et al. Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice. Vet Pathol. 2022;59:613-626 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Maugeri N, De Lorenzo R, Clementi N, Antonia Diotti R, Criscuolo E, Godino C, et al. Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19. J Thromb Haemost. 2022;20:434-448 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Helms L, Marchianò S, Stanaway I, Hsiang T, Juliar B, Saini S, et al. Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations. JCI Insight. 2021;6: pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Wu X, Cheng L, Fu M, Huang B, Zhu L, Xu S, et al. A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration. Cell Rep. 2021;37:109869 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Li K, Meyerholz D, Bartlett J, McCray P. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. MBio. 2021;12:e0097021 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Stegmann K, Dickmanns A, Gerber S, Nikolova V, Klemke L, Manzini V, et al. The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models. Virus Res. 2021;302:198469 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Perrucci G, Sommariva E, Ricci V, Songia P, D Alessandra Y, Poggio P, et al. Presence of SARS-CoV-2 Nucleoprotein in Cardiac Tissues of Donors with Negative COVID-19 Molecular Tests. Diagnostics (Basel). 2021;11: pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Zhao M, Yu Y, Sun L, Xing J, Li T, Zhu Y, et al. GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein. Nat Commun. 2021;12:2114 pubmed publisher |
- ELISA; SARS coronavirus
- western blot; SARS coronavirus
| Wang B, Zhang C, Lei X, Ren L, Zhao Z, Wang J, et al. Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation. Virol Sin. 2021;: pubmed publisher |
| Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, et al. SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. Sci Immunol. 2021;6: pubmed publisher |
| Brustolin M, Rodon J, Rodríguez de la Concepción M, Ávila Nieto C, Cantero G, Perez M, et al. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster. Emerg Microbes Infect. 2021;10:797-809 pubmed publisher |
| Kim S, Hao Y, Miller E, Tay D, Yee E, Kongsuphol P, et al. Vertical Flow Cellulose-Based Assays for SARS-CoV-2 Antibody Detection in Human Serum. ACS Sens. 2021;6:1891-1898 pubmed publisher |
| Wang P, Luo R, Zhang M, Wang Y, Song T, Tao T, et al. A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection. Cell Death Dis. 2020;11:1042 pubmed publisher |
| Hekman R, Hume A, Goel R, Abo K, Huang J, Blum B, et al. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020;80:1104-1122.e9 pubmed publisher |
| Zheng J, Wong L, Li K, Verma A, Ortiz M, Wohlford Lenane C, et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature. 2021;589:603-607 pubmed publisher |
| Huang K, Lin M, Kuo T, Chen C, Lin C, Chou Y, et al. Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection. EMBO Mol Med. 2021;13:e12828 pubmed publisher |
| Szabolcs M, Sauter J, Frosina D, Geronimo J, Hernandez E, Selbs E, et al. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues. Appl Immunohistochem Mol Morphol. 2021;29:5-12 pubmed publisher |
| Segal xe9 s J, Puig M, Rodon J, Ávila Nieto C, Carrillo J, Cantero G, et al. Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain. Proc Natl Acad Sci U S A. 2020;117:24790-24793 pubmed publisher |
| Xu L, Yu D, Ma Y, Yao Y, Luo R, Feng X, et al. COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2. Zool Res. 2020;41:517-526 pubmed publisher |
| Bojkova D, Klann K, Koch B, Widera M, Krause D, Ciesek S, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583:469-472 pubmed publisher |
